Annual report
4360.TEDINET S100VYLQ
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 121
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥9.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥11.9bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥342m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | −¥105m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥275m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥10m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥881m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥794m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥80m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥895m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥82m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥821m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥712m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥895m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥83m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥12.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥15.0bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥13.6bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.8bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.3bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.0bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥108m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥118m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥714m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥489m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥231m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥199m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥422m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥126m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥75m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥125m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥200m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-110.77 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.3 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.26 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.52 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,271.5 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,399.56 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,384.71 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,300.81 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 81.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 0.7% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 211 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 220 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 236 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 241 | at 2022-03-31d | Cons. | Number of employees |
| Revenue | ¥547m | 2024-04-01 → 2025-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥541m | 2023-04-01 → 2024-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥672m | 2022-04-01 → 2023-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥317m | 2021-04-01 → 2022-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥100m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥91m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥159m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥517m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥760m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥188m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥159m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥593m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥124m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥534m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥662m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥174m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥12.1bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥11.9bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥11.2bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥10.6bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥234m | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥175m | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥11.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.7bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.1bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥10.5bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥15.41 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.73 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.29 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.05 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥12.5 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7.5 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,458.45 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,460.86 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,388.88 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,324.77 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 98.1% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 98.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 98.5% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.2% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 1.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,625,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,625,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,625,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,625,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 8 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 9 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 8 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 7 | at 2022-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥87m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥121m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥5.7bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.1bn |
| Fine Chemical Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥82m |
| Fine Chemical Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥197m |
| Fine Chemical Businessreportable segment | employees | at 2025-03-31 | 75 pure |
| Fine Chemical Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥3.9bn |
| Fine Chemical Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥3.9bn |
| Fine Chemical Businessreportable segment | segment assets | at 2025-03-31 | ¥3.7bn |
| Fine Chemical Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥603m |
| Flame Retardants Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥253m |
| Flame Retardants Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥140m |
| Flame Retardants Businessreportable segment | employees | at 2025-03-31 | 45 pure |
| Flame Retardants Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Flame Retardants Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Flame Retardants Businessreportable segment | segment assets | at 2025-03-31 | ¥2.4bn |
| Flame Retardants Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥72m |
| Health Support Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥24m |
| Health Support Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥21m |
| Health Support Businessreportable segment | employees | at 2025-03-31 | 11 pure |
| Health Support Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.4bn |
| Health Support Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.4bn |
| Health Support Businessreportable segment | segment assets | at 2025-03-31 | ¥846m |
| Health Support Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥54m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥360m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥359m |
| —segment total | employees | at 2025-03-31 | 131 pure |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥9.3bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥9.3bn |
| —segment total | segment assets | at 2025-03-31 | ¥6.9bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥729m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥97m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥122m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥6.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥1.1bn |
| Fine Chemical Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥127m |
| Fine Chemical Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥194m |
| Fine Chemical Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥3.9bn |
| Fine Chemical Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥3.9bn |
| Fine Chemical Businessreportable segment | segment assets | at 2024-03-31 | ¥4.0bn |
| Fine Chemical Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥615m |
| Flame Retardants Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥58m |
| Flame Retardants Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥128m |
| Flame Retardants Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥4.4bn |
| Flame Retardants Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥4.4bn |
| Flame Retardants Businessreportable segment | segment assets | at 2024-03-31 | ¥3.1bn |
| Flame Retardants Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥350m |
| Health Support Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥13m |
| Health Support Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥18m |
| Health Support Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Health Support Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Health Support Businessreportable segment | segment assets | at 2024-03-31 | ¥890m |
| Health Support Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥62m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥199m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥341m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥9.7bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥9.7bn |
| —segment total | segment assets | at 2024-03-31 | ¥8.0bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,420
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities | CurrentYearInstant_NonConsolidatedMember | 234000000 | JPY |
| Capital stock | Prior1YearInstant_NonConsolidatedMember | 300000000 | JPY |
| Capital stock | CurrentYearInstant_NonConsolidatedMember | 300000000 | JPY |
| Legal capital surplus | Prior1YearInstant_NonConsolidatedMember | 75000000 | JPY |
| Legal capital surplus | CurrentYearInstant_NonConsolidatedMember | 75000000 | JPY |
| Other capital surplus | Prior1YearInstant_NonConsolidatedMember | 10291000000 | JPY |
| Other capital surplus | CurrentYearInstant_NonConsolidatedMember | 10284000000 | JPY |
| Capital surplus | Prior1YearInstant_NonConsolidatedMember | 10366000000 | JPY |
| Capital surplus | CurrentYearInstant_NonConsolidatedMember | 10359000000 | JPY |
| Retained earnings brought forward | Prior1YearInstant_NonConsolidatedMember | 1131000000 | JPY |
| Retained earnings brought forward | CurrentYearInstant_NonConsolidatedMember | 1135000000 | JPY |
| Retained earnings | Prior1YearInstant_NonConsolidatedMember | 1131000000 | JPY |
| Retained earnings | CurrentYearInstant_NonConsolidatedMember | 1135000000 | JPY |
| Treasury stock | Prior1YearInstant_NonConsolidatedMember | -426000000 | JPY |
| Treasury stock | CurrentYearInstant_NonConsolidatedMember | -377000000 | JPY |
| Shareholders equity | Prior1YearInstant_NonConsolidatedMember | 11371000000 | JPY |
| Shareholders equity | CurrentYearInstant_NonConsolidatedMember | 11417000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant_NonConsolidatedMember | 370000000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant_NonConsolidatedMember | 403000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant_NonConsolidatedMember | 370000000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant_NonConsolidatedMember | 403000000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember | 11742000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember | 11821000000 | JPY |
| Liabilities and net assets | Prior1YearInstant_NonConsolidatedMember | 11917000000 | JPY |
| Liabilities and net assets | CurrentYearInstant_NonConsolidatedMember | 12055000000 | JPY |
| Consulting fee income rev oa | Prior1YearDuration_NonConsolidatedMember | 541000000 | JPY |
| Consulting fee income rev oa | CurrentYearDuration_NonConsolidatedMember | 547000000 | JPY |
| Operating revenue1 | Prior1YearDuration_NonConsolidatedMember | 541000000 | JPY |
| Operating revenue1 | CurrentYearDuration_NonConsolidatedMember | 547000000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration_NonConsolidatedMember | 449000000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration_NonConsolidatedMember | 447000000 | JPY |
| Operating expenses | Prior1YearDuration_NonConsolidatedMember | 449000000 | JPY |
| Operating expenses | CurrentYearDuration_NonConsolidatedMember | 447000000 | JPY |
| Operating income | Prior1YearDuration_NonConsolidatedMember | 91000000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember | 100000000 | JPY |
| Interest and dividends income noi | Prior1YearDuration_NonConsolidatedMember | 426000000 | JPY |
| Interest and dividends income noi | CurrentYearDuration_NonConsolidatedMember | 49000000 | JPY |
| Other noi | Prior1YearDuration_NonConsolidatedMember | 1000000 | JPY |
| Other noi | CurrentYearDuration_NonConsolidatedMember | 9000000 | JPY |
| Non operating income | Prior1YearDuration_NonConsolidatedMember | 428000000 | JPY |
| Non operating income | CurrentYearDuration_NonConsolidatedMember | 59000000 | JPY |
| Miscellaneous loss noe | Prior1YearDuration_NonConsolidatedMember | 2000000 | JPY |
| Miscellaneous loss noe | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Non operating expenses | Prior1YearDuration_NonConsolidatedMember | 2000000 | JPY |
| Non operating expenses | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Ordinary income | Prior1YearDuration_NonConsolidatedMember | 517000000 | JPY |
| Ordinary income | CurrentYearDuration_NonConsolidatedMember | 159000000 | JPY |
| Gain on sales of investment securities ei | Prior1YearDuration_NonConsolidatedMember | 76000000 | JPY |
| Gain on sales of investment securities ei | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Extraordinary income | Prior1YearDuration_NonConsolidatedMember | 76000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |